Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028605 |
---|---|
Receipt number | R000032727 |
Scientific Title | A retrospective study for ALK positive Lung Cancer - The Clinical Benefits of Sequential Therapy using Crizotinib followed by Alectinib in Clinical Practice: A Multicenter Retrospective Study. - (WJOG9516L) |
Date of disclosure of the study information | 2017/08/09 |
Last modified on | 2021/10/08 17:09:59 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/08/09 16:52:31 | ||
2 | Update | 2017/09/05 16:11:13 | Organization Organization Organization Category of Funding Organization |
|
3 | Update | 2017/12/27 19:01:01 | Recruitment status |
|
4 | Update | 2019/08/20 15:06:47 | Recruitment status Date of IRB Last follow-up date |
|
5 | Update | 2021/10/08 17:09:59 | Recruitment status |